Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences

Therapeutic implications for India

Ujjwal Neogi, Sreenivasa B. Prarthana, George D'Souza, Ayesha DeCosta, Vijesh S. Kuttiatt, Udaykumar Ranga, Anita Shet

Research output: Contribution to journalArticle

Abstract

Background: Understanding co-receptor tropism of HIV-1 strains circulating in India will provide key analytical leverage for assessing the potential usefulness of newer antiretroviral drugs such as chemokine co-receptor antagonists among Indian HIV-infected populations. The objective of this study was to determine using in silico methods, HIV-1 tropism among a large number of Indian isolates both from primary clinical isolates as well as from database-derived sequences.Results: R5-tropism was seen in 96.8% of a total of 1045 HIV-1 subtype C Indian sequences. Co-receptor prediction of 15 primary clinical isolates detected two X4-tropic strains using the C-PSSM matrix. R5-tropic HIV-1 subtype C V3 sequences were conserved to a greater extent than X4-tropic strains. X4-tropic strains were obtained from subjects who had a significantly longer time since HIV diagnosis (96.5 months) compared to R5-tropic strains (20.5 months).Conclusions: High prevalence of R5 tropism and greater homogeneity of the V3 sequence among HIV-1 subtype C strains in India suggests the potential benefit of CCR5 antagonists as a therapeutic option in India.

Original languageEnglish (US)
Article number24
JournalAIDS Research and Therapy
Volume7
DOIs
StatePublished - Jul 21 2010
Externally publishedYes

Fingerprint

Tropism
HIV-1
India
HIV
Therapeutics
Conserved Sequence
Chemokine Receptors
Computer Simulation
Databases
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Molecular Medicine
  • Virology
  • Pharmacology (medical)

Cite this

Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences : Therapeutic implications for India. / Neogi, Ujjwal; Prarthana, Sreenivasa B.; D'Souza, George; DeCosta, Ayesha; Kuttiatt, Vijesh S.; Ranga, Udaykumar; Shet, Anita.

In: AIDS Research and Therapy, Vol. 7, 24, 21.07.2010.

Research output: Contribution to journalArticle

Neogi, Ujjwal ; Prarthana, Sreenivasa B. ; D'Souza, George ; DeCosta, Ayesha ; Kuttiatt, Vijesh S. ; Ranga, Udaykumar ; Shet, Anita. / Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences : Therapeutic implications for India. In: AIDS Research and Therapy. 2010 ; Vol. 7.
@article{3dad650da8f445a28533d73dbb27e113,
title = "Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India",
abstract = "Background: Understanding co-receptor tropism of HIV-1 strains circulating in India will provide key analytical leverage for assessing the potential usefulness of newer antiretroviral drugs such as chemokine co-receptor antagonists among Indian HIV-infected populations. The objective of this study was to determine using in silico methods, HIV-1 tropism among a large number of Indian isolates both from primary clinical isolates as well as from database-derived sequences.Results: R5-tropism was seen in 96.8{\%} of a total of 1045 HIV-1 subtype C Indian sequences. Co-receptor prediction of 15 primary clinical isolates detected two X4-tropic strains using the C-PSSM matrix. R5-tropic HIV-1 subtype C V3 sequences were conserved to a greater extent than X4-tropic strains. X4-tropic strains were obtained from subjects who had a significantly longer time since HIV diagnosis (96.5 months) compared to R5-tropic strains (20.5 months).Conclusions: High prevalence of R5 tropism and greater homogeneity of the V3 sequence among HIV-1 subtype C strains in India suggests the potential benefit of CCR5 antagonists as a therapeutic option in India.",
author = "Ujjwal Neogi and Prarthana, {Sreenivasa B.} and George D'Souza and Ayesha DeCosta and Kuttiatt, {Vijesh S.} and Udaykumar Ranga and Anita Shet",
year = "2010",
month = "7",
day = "21",
doi = "10.1186/1742-6405-7-24",
language = "English (US)",
volume = "7",
journal = "AIDS Research and Therapy",
issn = "1742-6405",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences

T2 - Therapeutic implications for India

AU - Neogi, Ujjwal

AU - Prarthana, Sreenivasa B.

AU - D'Souza, George

AU - DeCosta, Ayesha

AU - Kuttiatt, Vijesh S.

AU - Ranga, Udaykumar

AU - Shet, Anita

PY - 2010/7/21

Y1 - 2010/7/21

N2 - Background: Understanding co-receptor tropism of HIV-1 strains circulating in India will provide key analytical leverage for assessing the potential usefulness of newer antiretroviral drugs such as chemokine co-receptor antagonists among Indian HIV-infected populations. The objective of this study was to determine using in silico methods, HIV-1 tropism among a large number of Indian isolates both from primary clinical isolates as well as from database-derived sequences.Results: R5-tropism was seen in 96.8% of a total of 1045 HIV-1 subtype C Indian sequences. Co-receptor prediction of 15 primary clinical isolates detected two X4-tropic strains using the C-PSSM matrix. R5-tropic HIV-1 subtype C V3 sequences were conserved to a greater extent than X4-tropic strains. X4-tropic strains were obtained from subjects who had a significantly longer time since HIV diagnosis (96.5 months) compared to R5-tropic strains (20.5 months).Conclusions: High prevalence of R5 tropism and greater homogeneity of the V3 sequence among HIV-1 subtype C strains in India suggests the potential benefit of CCR5 antagonists as a therapeutic option in India.

AB - Background: Understanding co-receptor tropism of HIV-1 strains circulating in India will provide key analytical leverage for assessing the potential usefulness of newer antiretroviral drugs such as chemokine co-receptor antagonists among Indian HIV-infected populations. The objective of this study was to determine using in silico methods, HIV-1 tropism among a large number of Indian isolates both from primary clinical isolates as well as from database-derived sequences.Results: R5-tropism was seen in 96.8% of a total of 1045 HIV-1 subtype C Indian sequences. Co-receptor prediction of 15 primary clinical isolates detected two X4-tropic strains using the C-PSSM matrix. R5-tropic HIV-1 subtype C V3 sequences were conserved to a greater extent than X4-tropic strains. X4-tropic strains were obtained from subjects who had a significantly longer time since HIV diagnosis (96.5 months) compared to R5-tropic strains (20.5 months).Conclusions: High prevalence of R5 tropism and greater homogeneity of the V3 sequence among HIV-1 subtype C strains in India suggests the potential benefit of CCR5 antagonists as a therapeutic option in India.

UR - http://www.scopus.com/inward/record.url?scp=77954686960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954686960&partnerID=8YFLogxK

U2 - 10.1186/1742-6405-7-24

DO - 10.1186/1742-6405-7-24

M3 - Article

VL - 7

JO - AIDS Research and Therapy

JF - AIDS Research and Therapy

SN - 1742-6405

M1 - 24

ER -